CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 230 enrolled
Drug / intervention
High Dose Vitamin D3 +2 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00933244
NCT00933244Phase 4Completed

Treatment of Vitamin D Insufficiency

University of Wisconsin, Madison·interventional·Posted Jul 7, 2009·Updated Nov 10, 2015

In Brief

A Phase 4 clinical trial evaluating High Dose Vitamin D3, Low Dose Vitamin D3, and 1 other intervention for Vitamin D Deficiency. Completed, enrolled 230 participants across 1 site.

Detailed Summary

The purpose of this study is to answer the following questions: Does vitamin D increase calcium absorption, bone mass and muscle mass and function in women past menopause who have mildly low vitamin D levels? Do these benefits require prescription-strength vitamin D, or is an over the counter vitamin D dose enough?

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

Phase 4CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedJul 7, 2009
Enrollment StartApr 1, 2010
Primary CompletionAug 1, 2014
TodayJul 2, 2026
Enrollment to primary: 4.3 yearsPosted 17.0 years ago

Interventions

High Dose Vitamin D3dietary

Yellow gel-cap vitamin D3 at 50,000 International Units daily for 15 days then two times a month for 350 days. Daily white placebo pills.

Low Dose Vitamin D3dietary

White gel-cap vitamin D3 at 800 International Units to take orally, daily for 365 days. Intermittent yellow placebo pills.

Placebodietary

Yellow gel-cap placebo pills to take orally, daily for 15 days then two times a month for 350 days. White gel-cap placebo pills once daily for 365 days.